PELUCCHI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 9.501
AS - Asia 4.225
EU - Europa 3.790
SA - Sud America 716
Continente sconosciuto - Info sul continente non disponibili 328
AF - Africa 100
OC - Oceania 11
Totale 18.671
Nazione #
US - Stati Uniti d'America 9.008
SG - Singapore 1.505
CN - Cina 983
IT - Italia 841
DE - Germania 570
BR - Brasile 538
HK - Hong Kong 515
RU - Federazione Russa 497
VN - Vietnam 487
CA - Canada 423
SE - Svezia 414
IE - Irlanda 331
GB - Regno Unito 240
UA - Ucraina 231
FR - Francia 186
IN - India 144
FI - Finlandia 118
BD - Bangladesh 115
KR - Corea 68
AT - Austria 66
TR - Turchia 62
NL - Olanda 60
AR - Argentina 54
IQ - Iraq 52
ES - Italia 49
JP - Giappone 45
ID - Indonesia 44
PK - Pakistan 39
MX - Messico 38
BE - Belgio 35
DK - Danimarca 34
ZA - Sudafrica 33
CO - Colombia 31
PL - Polonia 30
EC - Ecuador 27
PH - Filippine 27
VE - Venezuela 27
UZ - Uzbekistan 23
SA - Arabia Saudita 22
LT - Lituania 17
PY - Paraguay 13
MA - Marocco 12
CH - Svizzera 11
ET - Etiopia 11
MY - Malesia 11
AU - Australia 9
IR - Iran 9
CL - Cile 8
CZ - Repubblica Ceca 8
EG - Egitto 8
KE - Kenya 8
NP - Nepal 8
JO - Giordania 7
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
TN - Tunisia 7
BG - Bulgaria 6
CR - Costa Rica 6
HU - Ungheria 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
KZ - Kazakistan 5
PT - Portogallo 5
RS - Serbia 5
UY - Uruguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
MT - Malta 4
NG - Nigeria 4
OM - Oman 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
SV - El Salvador 3
TW - Taiwan 3
AL - Albania 2
CG - Congo 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TG - Togo 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
Totale 18.319
Città #
Ann Arbor 1.285
Ashburn 977
Singapore 928
San Jose 556
Woodbridge 556
Hong Kong 493
Fairfield 446
Houston 394
Chandler 388
Frankfurt am Main 348
Dublin 318
Toronto 288
Milan 282
Wilmington 258
Jacksonville 238
New York 224
Los Angeles 189
Dearborn 186
Seattle 183
Santa Clara 160
Cambridge 152
Ho Chi Minh City 149
Beijing 148
Dallas 134
Chicago 117
Princeton 115
The Dalles 108
Hanoi 104
Nanjing 95
Hefei 84
Buffalo 74
Shanghai 73
Lauterbourg 63
Seoul 61
São Paulo 60
Boardman 58
Vienna 58
Rome 57
Orem 54
Council Bluffs 52
Lawrence 51
Munich 47
Altamura 45
Moscow 43
Helsinki 41
Columbus 40
Lachine 40
San Diego 37
Tokyo 32
Brussels 31
Denver 29
Atlanta 28
Nanchang 28
San Francisco 28
Jakarta 27
Montreal 27
Turku 27
Dong Ket 26
London 26
Rio de Janeiro 25
Turin 25
Ottawa 24
Phoenix 24
Shenyang 24
Tianjin 22
Brooklyn 21
Guangzhou 21
Johannesburg 21
Chennai 20
Warsaw 20
Boston 18
Hebei 18
Jinan 18
Tashkent 18
Andover 17
Da Nang 17
Poplar 17
Jiaxing 16
Stockholm 16
Zhengzhou 16
Changsha 15
Dhaka 15
Tampa 15
Haiphong 14
Mumbai 14
Nuremberg 14
Washington 14
Baghdad 13
Indianapolis 12
Mexico City 12
Belo Horizonte 11
Brasília 11
Campinas 11
Huizen 11
Naples 11
Philadelphia 11
Quito 11
Addis Ababa 10
Biên Hòa 10
Curitiba 10
Totale 11.829
Nome #
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 895
Hepcidin regulation in a mouse model of acute hypoxia 600
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 450
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 416
Idiopathic erythrocytosis: a germline disease? 389
Hif1a: A putative modifier of hemochromatosis 387
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 385
Inherited iron overload disorders 354
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 354
Type 3 hemochromatosis and beta-thalassemia trait 344
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 340
Hepcidin regulation in a mouse model of acute hypoxia 339
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 338
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 334
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 333
Unexplained isolated hyperferritinemia without iron overload 328
Circulating factors are involved in hypoxia-induced hepcidin suppression 320
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 311
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 307
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 303
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 300
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 299
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 298
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 292
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 288
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 286
Ferroportin disease: A novel SLC40A1 mutation 285
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 282
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 277
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 275
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 273
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 272
Ceruloplasmin variants might have different effects in different iron overload disorders 270
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 269
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 269
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 262
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 262
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 262
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: The causes might be more heterogeneous than in thalassaemia 261
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 259
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 254
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 253
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 249
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 248
Homozygous deletion of HFE: The Sardinian hemochromatosis? 239
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 228
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 228
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 225
Angiotensin type 2 and mas receptor activation prevents myocardial fibrosis and hypertrophy through the reduction of inflammatory cell infiltration and local sympathetic activity in angiotensin ii‐dependent hypertension 222
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 221
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 218
Hereditary Hyperferritinemia 218
Total iron-overload measurement in the human liver region by the magnetic iron detector. 216
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 215
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 210
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia 206
Erythrocytapheresis plus erythropoietin: An alternative therapy for selected patients with hemochromatosis and severe organ damage 199
Interaction Between the PNPLA3 I148M Mutation, Body Weight, And Steatosis, In Determining The Progression To Cirrhosis In Hereditary Hemochromatosis 197
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis 196
Hypoxia-dependent hepcidin down-regulation: an in vitro study 191
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 188
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 163
Gene symbol: FTL. Disease: Hyperferritinemia-cataract syndrome 144
Molecular testing in hemochromatosis 137
Emerging nanocarrier systems for the enhanced delivery of active pharmaceutical ingredients to the intestine 136
Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis 76
New mutations in hfe2 and tfr2 genes causing non hfe-related hereditary hemochromatosis 18
A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1 8
Totale 18.671
Categoria #
all - tutte 56.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022899 0 93 106 76 70 56 62 51 40 74 81 190
2022/20231.529 205 429 155 156 101 222 10 84 95 10 30 32
2023/2024982 40 48 43 45 107 272 194 50 42 15 18 108
2024/20252.288 122 193 114 91 238 104 132 110 261 374 220 329
2025/20266.883 721 334 473 749 880 372 1.004 271 541 634 454 450
2026/20271.083 700 383 0 0 0 0 0 0 0 0 0 0
Totale 18.671